Glycohemoglobin-Skreen Test Kit
by Eppendorf-Brinkmann, Inc. 510(k)
Active
510(k) K780819
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK780819 | Date7 Nov 1978 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- LCP
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.7470
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The Glycohemoglobin-Skreen Test Kit is an assay for glycosylated hemoglobin used in hematology. It is a diagnostic test designed to measure levels of glycosylated hemoglobin in blood samples.
Supplied as a test kit, it is intended for use in clinical laboratory settings. The device received FDA 510(k) clearance (K780819) on November 7, 1978, and is classified as a Class II medical device under regulation number 864.7470. It is manufactured by Eppendorf-Brinkmann, Inc. and distributed in the United States.
Other devices from Eppendorf-Brinkmann, Inc.
Questions
AI-generated answers, 21 Sep 2026
What is the Glycohemoglobin-Skreen Test Kit used for?
The Glycohemoglobin-Skreen Test Kit is an assay designed to measure levels of glycosylated hemoglobin in blood samples. It is used in hematology to assess long-term blood glucose control, providing diagnostic information for conditions such as diabetes.
How is the Glycohemoglobin-Skreen Test Kit supplied and where is it intended for use?
The device is supplied as a test kit and is intended for use in clinical laboratory settings. It is distributed in the United States by Eppendorf-Brinkmann, Inc. for professional diagnostic testing of blood samples.
Is the Glycohemoglobin-Skreen Test Kit a single-use or reusable device?
The Glycohemoglobin-Skreen Test Kit is supplied as a test kit, which implies it contains reagents and components for performing the assay. Based on its description as an in vitro diagnostic test kit, it is intended for single-use per test, though the kit may allow multiple tests depending on the number of tests included.
What regulatory pathway was used for the Glycohemoglobin-Skreen Test Kit and what is its classification?
The device received FDA 510(k) clearance under submission K780819 on November 7, 1978. It is classified as a Class II medical device under regulation number 864.7470, with product code LCP, and was found substantially equivalent to a predicate device.
What are the storage and handling requirements for the Glycohemoglobin-Skreen Test Kit?
The device data does not specify storage conditions, temperature requirements, or shelf life for the Glycohemoglobin-Skreen Test Kit. Users should consult the manufacturer’s labeling or instructions for use for proper storage and handling guidance.